SCHIZOPHRENIFORM DISORDERS

This study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 participants received either the drug or a placebo, and researchers measured changes in agitation levels and sa…

This study tested whether delivering mental health services through telehealth (video calls) helps young adults with psychotic disorders stay engaged in care and avoid hospital stays better than standard in-person clinic visits. Seventy-four participants aged 16 to 35 with recent…

This study looked at how young adults aged 18-30 with early psychosis process information about their surroundings, compared to those without a psychiatric diagnosis. Researchers used computer-based tasks and cognitive training to measure changes in thinking skills. The goal was …

This study tested whether sending text message reminders to young people (ages 14-35) who had a first episode of psychosis could help them attend their first appointment at an early psychosis program after being seen in the emergency department. The study involved 186 participant…

This study looked at how the body builds tolerance to Igalmi (a fast-acting medicine for agitation) and what happens when it's stopped. It involved 29 adults with schizophrenia or bipolar disorder who had frequent agitation. Researchers measured changes in agitation levels and wa…

This study looked at whether a program called NAVIGATE helps youth (ages 14-35) having their first episode of psychosis get better coordinated care. Researchers worked with 100 participants across Ontario to see if the program reduces hospital stays and ER visits. The goal was to…

This study looked at whether family members or caregivers can help measure agitation in people with bipolar disorder or schizophrenia. 33 adults took a single dose of an experimental medicine, and researchers compared ratings from doctors, patients, and their family members. The …